Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
DuneGlass Capital is a growth-oriented investment firm founded in 2018 and headquartered in Chicago, Illinois. The firm specializes in partnering with healthcare founders to enhance the value of their practices through its proprietary model known as Doctor Equity™. This model aligns the interests of founders, investors, and employees, ultimately generating better returns. DuneGlass Capital has established itself as a key player in the healthcare investment space, focusing on building platforms across various medical specialties.
As of now, DuneGlass Capital operates multiple platforms tailored for different medical specialties, including oral surgery, obesity treatment, medical aesthetics, and specialty dental services. The firm has developed a reputation for enhancing operational efficiencies and growth strategies for its portfolio companies. The firm’s unique approach allows it to leverage its expertise and resources to drive innovation and improve patient outcomes.
Currently, DuneGlass Capital has a team of experienced professionals dedicated to supporting its portfolio companies. The firm continues to explore new opportunities within the healthcare sector, aiming to expand its influence and impact in the industry.
DuneGlass Capital primarily invests in the healthcare sector, specifically targeting entrepreneurial founders with a growth mindset. The firm focuses on various medical specialties, including oral and maxillofacial surgery, bariatric and general surgery, orthodontics, and pediatric dentistry. This strategic focus allows DuneGlass to leverage its expertise and resources to drive innovation and improve patient outcomes.
The firm employs a unique platform model that integrates private practice with private equity, allowing healthcare founders to maximize their practice value while maintaining clinical autonomy. DuneGlass Capital's Doctor Equity™ model inverts the traditional healthcare private equity structure by enabling physician-founders to retain majority ownership and clinical control while benefiting from private equity management expertise. This approach fosters a collaborative environment where founders can thrive and innovate.
DuneGlass Capital has developed several thematic investments within the healthcare sector, focusing on platforms that address specific medical needs. The firm’s notable platforms include:
Ryan Graham - Managing Partner | Founder. Ryan has extensive experience in healthcare investments and has co-founded the Doctor Equity™ model.
Daniel Hosler - Managing Partner | Founder. Daniel is also a co-founder of the Doctor Equity™ model and plays a key role in shaping the firm's investment strategy.
Brian Hamilton - Managing Director. Brian serves as Chairman of Phase 1 Equity and was previously the Chief Development Officer at Allied OMS, leading significant growth initiatives.
Sara Weinberg - Principal. Sara contributes to the firm's investment analysis and portfolio management efforts.
Omer Karaayvaz - Principal. Omer focuses on identifying new investment opportunities and supporting portfolio companies.
Zach Katsulis - Vice President. Zach plays a role in deal sourcing and due diligence for potential investments.
Emily Tumen - Creative Director. Emily oversees the firm's branding and communication strategies.
Summer Ugel - Executive Assistant. Summer provides administrative support to the team and assists in operational functions.
To pitch DuneGlass Capital, founders should utilize the contact page on the firm's website to initiate communication. A well-prepared pitch deck should include details about the business model, market opportunity, and growth strategy. While specific application forms or portals are not mentioned, a direct approach through the contact page is recommended.
Response times may vary, but founders should expect a thorough review process given the firm's focus on healthcare investments. Warm introductions may enhance the chances of securing a meeting with the investment team.
In May 2024, DuneGlass Capital announced that Allied OMS secured a $116 million credit facility from four leading healthcare banks, marking a significant milestone for the platform.
In February 2023, DuneGlass Capital launched Phase 1 Equity, a private equity firm dedicated to orthodontists and pediatric dentists, emphasizing a doctor-led and doctor-owned structure.
In 2023, DuneGlass Capital participated in the Becker’s Spring Future of Dentistry Roundtable, sharing insights on private equity investments in dental service organizations.
What are DuneGlass Capital's investment criteria?
DuneGlass Capital focuses on investing in the healthcare sector, specifically targeting entrepreneurial founders with a growth mindset. The firm seeks to partner with companies that operate in various medical specialties, including oral surgery, obesity treatment, medical aesthetics, and specialty dental services.
How can founders apply or pitch to DuneGlass Capital?
Founders interested in pitching to DuneGlass Capital should prepare a comprehensive presentation that outlines their business model, market opportunity, and growth strategy. It is advisable to reach out through the firm's contact page for initial inquiries.
What makes DuneGlass Capital different from other investors?
DuneGlass Capital differentiates itself through its Doctor Equity™ model, which allows physician-founders to retain majority ownership and clinical control while benefiting from private equity management expertise. This model fosters a collaborative environment that aligns the interests of founders, investors, and employees.
What is the geographic scope of DuneGlass Capital's investments?
The firm primarily invests in the United States, focusing on healthcare startups that operate within the country.
What kind of post-investment involvement does DuneGlass Capital have?
DuneGlass Capital provides operational support, industry expertise, and access to capital for its portfolio companies. The firm is actively involved in enhancing the operational efficiencies and growth strategies of its investments.
What is the typical check size for investments made by DuneGlass Capital?
While specific check sizes are not publicly disclosed, DuneGlass Capital focuses on growth equity investments, which typically involve significant capital to support the scaling of healthcare businesses.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.